Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen *
Pharmacy Only: Prescription
Show product notice

  • Company:

    AstraZeneca Pharmaceuticals (Ireland) DAC
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.

Product Notice

Discontinued Strength Notice

Bydureon 2 mg Powder and Solvent for Prolonged-Release Suspension for Injection in Pre-Filled Pen has been discontinued. It is expected that stock will be depleted by September 2022.